T1	Participants 454 516	Patients with AS patients who had predominantly axial symptoms
T2	Participants 1133 1308	Twenty-six patients were included (infliximab group: n = 12, infliximab + MTX group: n = 14), and 507 serum samples were available for measurement of infliximab concentration.
